n chronic steroids should be counseled about their increased risk for these complications, and both preoperative risk stratification and optimization should be employed to minimize perioperative risk.Preoperative chronic steroid use is independently associated with increased odds of major, minor, and infectious complications after open and arthroscopic rotator cuff repair, shoulder stabilization, and associated procedures. Patients on chronic steroids should be counseled about their increased risk for these complications, and both preoperative risk stratification and optimization should be employed to minimize perioperative risk.Intermittent auscultation (IA) of fetal heart has become acceptable in low risk labors even in the developed countries. However, the instances of birth asphyxia occur despite adhering to the guidelines. Such outcomes need not be the inherent limitations of IA, but improvements in the IA regime are highly desirable. The systematic analyses of available studies have been unhelpful to ascertain an optimal regime or suggest improvements. This analytical review uses detailed modeling and reasoning to examine/propose safe and effective regime. It counters a misconception that the Doppler-device is not superior to Pinard stethoscope in usability, accuracy and thereby decision making. Importantly, the Doppler-device should not be used to actually count the fetal heart tones (like a Pinard stethoscope) as insisted by many guidelines. The review demonstrates that counting to 120-160 over a minute is arduous, superfluous and fraught with fallacies and risks. Observation of the digital read-out of the fetal heart rate (FHR) and its trend during the auscultation duration is far more informative. IA should focus on the two FHR parameters namely the baseline and late decelerations. Detection of additional FHR changes like overshoots, cycling or accelerations do not add value. Doppler-device FHR readouts over a steady pattern (commonly just before the contraction) best represent the baseline. FHR observation (IA) should commence in the later part of the contraction and continue till the beginning of next contraction and need not arbitrarily end at 1 min (a legacy of preoccupation with actual counting). Heightened awareness is required to detect late decelerations at the end of contractions. It would suffice to perform IA over a couple of contractions every 20-30 min during the first stage of labor. This improved methodology would avoid mistakes and improve the detection of FHR abnormalities to enhance patient safety in future practice guidelines.The optimal chemotherapy-free regimens for treatment-naive CLL still remains undefined. We searched relevant published reports. Three trials with 1017 subjects were identified. In the network meta-analysis, acalabrutinib plus obinutuzumab (Aca + Obi) improved PFS than ibrutinib plus obinutuzumab (Ibu + Obi) (HR0.43, p = .02) and venetoclax plus obinutuzumab (Ven + Obi) (HR0.30, p  less then  .001) as IRC assessment. Sensitivity analysis of investigator assessment also showed improved PFS with Aca + Obi than Ibu + Obi (HR0.46, p = .04) and Ven + Obi (HR0.34, p = .002). Among these first-line treatments (Aca + Obi, Ibu + Obi, Ven + Obi and chlorambucil plus obinutuzumab (Chl + Obi)), Aca + Obi regimen had the highest probability of 99.1% (IRC assessment) or 98.0% (investigator assessment) to reach the longest PFS. The survival advantage with Aca + Obi was not statistically significant, compared to Ibu + Obi (HR0.51, p = .21) and Ven + Obi (HR0.38, p = .07). No significant difference was found in AEs analysis. Our data indicated that Aca + Obi seemed to prolong the PFS than Ibu + Obi and Ven + Obi. Considering our limits, prospective clinical trials directly comparing these regimens are warranted.Innate immunomodulation via induction of innate memory is one mechanism to alter the host's innate immune response to reduce or prevent disease. Microbial products modulate innate responses with immediate and lasting effects. Innate memory is characterized by enhanced (training) or depressed (tolerance) innate immune responses, including pro-inflammatory cytokine production, to secondary exposure following a priming event. To investigate the ability of β-glucans and bacillus Calmette-Guerin to induce innate training or tolerance in pig cells, porcine monocytes were cultured with priming agonist (β-glucans or bacillus Calmette-Guerin) then re-stimulated 5 d later with a heterologous microbial agonist to determine induction of innate memory. Seladelpar Priming with β-glucan from Saccharomyces cerevisiae depressed IL-1β and TNF-α cytokine responses to re-stimulation with LPS, indicative of a tolerized state. However, bacillus Calmette-Guerin priming induced a trained state in porcine monocytes, as LPS re-stimulation enhanced IL-1β and TNF-α gene expression and protein production. We present the first evidence of innate memory in pig monocytes, with bacillus Calmette-Guerin (training) or Saccharomyces cerevisiae β-glucan (tolerance). Induction of a trained or tolerized state in vitro is a first step to identify agonists to alter the innate immune system at the animal level with the intent of enhancing disease resistance.The authors describe a rare presentation of invasive fungal rhino-orbital cellulitis caused by Saksenaea vasiformis in an immunocompetent child. The patient was initially diagnosed and treated as Mucoraceae, which has a high mortality rate and is primarily seen in immunocompromised patients. Though of the same order, Mucorales, the families Mucoraceae and Saksenaeacae, may be difficult to differentiate on histologic examination and must be distinguished by fungal culture and speciation. Our patient responded well to sino-orbital debridement and systemic treatment with amphotericin and posaconazole. To explore whether protective ileostomy is beneficial in preventing anastomotic leakage after anterior resection of rectal cancer. A total of 347 patients underwent anterior resection of rectal cancer in our hospital. Ninety-five patients were treated with protective ileostomy (treatment group), and 252 patients were not (control group). The incidences of anastomotic leakage and permanent stoma were compared between the two groups. The overall incidences of anastomotic leakage were 6.32% (6/95) and 8.73% (22/252) in the treatment group and control group, respectively. In the cohort of patients who underwent neoadjuvant radiotherapy, the incidence of anastomotic leakage was 5.88% (2/34) and 12.0% (3/25) in the treatment group and control group, respectively. Logistic regression showed that the incidence of anastomotic leakage was not statistically significant. However, diabetes and the anastomotic height significantly affected the occurrence of anastomotic leakage. The permanent stoma rate was 6.42% (6/95) and 5.